Skip to main navigation
logo
  • Home
  • Overview
  • News & Events
    • Press Releases
    • Events and Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Releases
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • IR Resources
    • Email Alerts
    • Contact IR

Press Releases

Press Releases

August 5, 2021
Athira Pharma Mourns the Loss of Chair of Board of Directors, Tadataka Yamada, M.D.
July 19, 2021
Athira Pharma to Present ATH-1017 Phase 1 Translational Data at the Alzheimer’s Association International Conference 2021 (AAIC)
July 6, 2021
Athira Pharma Announces Initiation of Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of ATH-1017 for Alzheimer’s Disease
June 17, 2021
Athira Pharma Chief Operating Officer, Mark Litton, Assumes Day-to-Day Leadership Responsibilities of Company
June 14, 2021
Athira Pharma Appoints Rachel Lenington as Chief Technology Officer, Head of Product Development Strategy
June 9, 2021
Athira Pharma to Present at Upcoming Investor Conferences
June 1, 2021
Athira Pharma Appoints Mark Worthington as General Counsel
May 26, 2021
Athira Pharma to Present at Upcoming Investor Conferences
May 13, 2021
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights
April 21, 2021
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Current page 11
  • Page 12
  • Page 13
  • Page 14
  • Next page next ›
  • Last page last »
Displaying 101 - 110 of 139
< SIGN UP FOR EMAIL ALERTS
CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

info@athira.com

FCOI Policy

Privacy Policy

© Athira Pharma, Inc. All rights reserved.